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A B S T R A C T
The mitochondrial electron transport chain is a major source of reactive oxygen species (ROS) and is also a target
of ROS, with an implied role in the stabilization of hypoxia-inducible factor (HIF) and induction of the AMPK
pathway. Here we used varying doses of two agents, Mito-Paraquat and Mito-Metformin, that have been con-
jugated to cationic triphenylphosphonium (TPP+) moiety to selectively target them to the mitochondrial matrix
compartment, thereby resulting in the site-specific generation of ROS within mitochondria. These agents pri-
marily induce superoxide (O2•–) production by acting on complex I. In Raw264.7 macrophages, C2C12 skeletal
myocytes, and HCT116 adenocarcinoma cells, we show that mitochondria-targeted oxidants can induce ROS
(O2•– and H2O2). In all three cell lines tested, the mitochondria-targeted agents disrupted membrane potential
and activated calcineurin and the Cn-dependent retrograde signaling pathway. Hypoxic culture conditions also
induced Cn activation and HIF1α activation in a temporally regulated manner, with the former appearing at
shorter exposure times. Together, our results indicate that mitochondrial oxidant-induced retrograde signaling is
driven by disruption of membrane potential and activation of Ca2+/Cn pathway and is independent of ROS-
induced HIF1α or AMPK pathways.
1. Introduction
Mitochondria are the major cellular producers of reactive oxygen
species (ROS), generated as byproducts of electron transport-linked
ATP synthesis. It is estimated that up to 1–2% of the total oxygen
consumed by mitochondria can be converted to superoxide (O2•–) [1].
Altered production of ROS destabilizes mitochondrial redox balance
and affects mitochondrial DNA and membrane functions [2]. Mi-
tochondria and mitochondrial ROS are major players in various pa-
thophysiological processes, including neurodegeneration, athero-
sclerosis, aging, and cancer [3]. Mitochondrial ROS are also involved in
reprogramming cells for proliferation [4,5] through altered metabolism
and retrograde signaling and are also implicated in other physiologi-
cally critical signaling pathways.
As the maintenance of mitochondrial number, morphology, in-
tracellular distribution, and functional integrity is critical, mechanisms
are in place to maintain these characteristics in response to changes in
developmental, physiological, and environmental conditions [6]. The
mitochondrial anterograde response, encompassing changes in nuclear
gene expression that affect mitochondrial structure and function, has
been known for more than four decades [7]. Mitochondrial retrograde
signaling (MtRS) (signaling from the mitochondria-to-the nucleus) was
first described in budding yeast in pioneering studies from Ronald
Butow's laboratory [8,9]. They showed that mitochondrial DNA
(mtDNA) depletion or deletion initiates retrograde (Rtg) signaling,
leading to adaptive changes in nuclear gene expression in response to
altered mitochondrial function.
Activation of the Rtg pathway appears to be restricted to unicellular
eukaryotes. In metazoans, induced nuclear gene expression in response
to mitochondrial genetic and metabolic changes have been reported in
several mammalian, avian, and nematode cells [9–12]. In support of
these observations, multiple mechanisms of MtRS, including the Ca2+/
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Calcineurin pathway [13], mitochondrial unfolded protein response
pathway (mtUPR) [14], mitochondrial ROS-induced AMPK pathway
[15], and the hypoxia-induced HIF1α activation pathway have been
reported in metazoan cells. In asynchronously proliferating Drosophila
eye disk cells, a mutation in the complex I subunit Pdsw gene, or mu-
tation in the cytochrome c oxidase Va (CcOVa) gene, can activate G1-S
checkpoint as a downstream effect of increased ROS production and
activation of the JNK signaling pathway [16]. It is not clear if these
multiple pathways have a common causative factor or they are acti-
vated independently to deal with different degrees of mitochondrial
dysfunction.
Most recently, mitochondrial defects have also been linked to im-
mune responses [17] and increased life span in mouse models [20].
Apparently, paradoxical roles of mitochondrial ROS in normal phy-
siology or pathology seem to depend on the activation or inhibition of
cellular signaling factors. In different cancer cells, the mitochondria-
generated superoxide can either promote or inhibit cell proliferation
[21]. In addition, mtDNA loss or uncoupling of the electron transport
chain (ETC) in mouse myoblast C2C12 cells causes increased tumor
invasiveness in xenograft mouse models [22]. With respect to the
Ca2+/Cn signaling, our overarching hypothesis is that loss of mi-
tochondrial membrane potential causes increased cytosolic Ca2+, re-
sulting in the activation of Cn [23]. Activation of NF-κB by Cn causes
nuclear translocation of the cRel:p50 heterodimer to regulate gene
expression in association with C/EBPδ, CREB and NFAT in a nuclear
enhanceosome complex [12], thus altering the cellular transcription
program.
Several studies have indicated that activation of the HIF1α pathway
of mammalian MtRS depends on mitochondrial ROS, as ρ° Hep3B cells
lacking mtDNA fail to activate HIF1α under hypoxic growth conditions
[24], presumably because complex III of the ETC is a source of ROS
production and concurrent stabilization of HIF1α [18,19]. In addition,
it has been proposed that respiratory complex III-generated superoxide
after conversion to H2O2 by superoxide dismutase (SOD), directly oxi-
dizes the non-heme-bound iron of prolyl hydroxylase (PHD), resulting
in PHD inactivation and HIF1α stabilization [24]. Low levels of oxygen
in the cytoplasm of highly respiring tissues can also inhibit PHD en-
zymes, further stabilizing HIF1α protein [25,26]. However, a study by
Masson et al. [27] reported that asparaginyl hydroxylase (FIH), an in-
activator of HIF, is more sensitive to hydrogen peroxide than is PHD.
Thus, the precise mechanism of action of mitochondrial ROS on the HIF
pathway may vary depending on the physiological state. An alternate
mechanism was proposed on the HIF1α stabilization by increased ROS
production at complex III [18,19] of the mitochondrial electron trans-
port chain.
In Caenorhabditis elegans, the mtUPR maintains mitochondrial
homeostasis by increasing the protein folding and degradation capacity
in response to the accumulation of unfolded and aggregated proteins in
mitochondria [14]. Subsequent to its initiation, mtUPR signaling pro-
motes alterations in proteostasis, organelle damage, or induces cellular
dysfunction and ultimately promotes nuclear changes that maintain the
functional integrity of mitochondria [28,29].
Based on multiple reports, it appears that mitochondrial ROS in-
duced by modulators of mitochondrial function or under hypoxic con-
ditions may induce multiple MtRS pathways, including the HIF
pathway [18], the Ca2+/Cn pathway [30] and the AMPK pathway [31].
Here, using hypoxia and mitochondria-targeted agents (MitoPQ and
MitoMet) as mitochondrial ROS inducers, we evaluated the time course
of Ca2+/Cn activation and HIF1α activation in Raw macrophages,
C2C12 myoblasts, and HCT116 colon carcinoma cells. We show that Cn
is activated well before the activation of HIF1α and that Cn alone is
able to induce MtRS and metabolic changes before the activation of
HIF1α or AMPK.
2. Materials and Methods
2.1. Cell culture conditions, treatments and exposure to hypoxia
Murine C2C12 skeletal myoblasts (ATCC CRL1772), Raw264.7
macrophages, human non-small cell lung carcinoma cell H1299, col-
orectal carcinoma cell line HCT116, p53+/+ and its isogenic p53 de-
ficient HCT116 p53−/− were grown in Dulbecco's modified Eagle's
medium (DMEM, Gibco, Life Technologies) as described before [32].
Cells were treated with different mitochondria-targeted agents
Mito-Paraquat (MitoPQ) (Fig. S1C) [33], Mito-Metformin (MitoMet)
(Fig. S1D) [34] which consist of a decyl triphenylphosphonium
(DTPP+) moiety conjugated to paraquat or Metformin and their cor-
responding controls. MitoPQ control is structurally similar to MitoPQ
but does not redox cycle because it has two extra methyl groups on the
pyridinium rings that disfavor coplanarity of the rings, which is ne-
cessary to stabilize a radical cation produced by one-electron reduction
(Fig: S1A). MitoMet control (decyl-TPP; DTPP) (Fig. S1B) has the same
aliphatic carbon chain linker without any functional group [35]. Cells
were grown under normal oxygen conditions of 150 Torr or 21% O2.
Cells grown up to 70–80% confluence under normoxia were latter ex-
posed to hypoxia for 2, 4, 6, 8, and 12 h. Simulation of realistic in vivo
hypoxia requires that O2 tension be maintained at less than 8 Torr (1%
O2). This hypoxic condition was achieved in a temperature controlled
hypoxic chamber by a constant flow of premixed gas that was certified
to contain 1.0% of oxygen and 5% CO2 (BOC gases, Murray Hill, NJ)
[30].
2.2. Generation of SOD2 expressing stable cell lines
A pCMV6 mammalian expression vector carrying human superoxide
dismutase-2 (sod2) cDNA (OriGene Technologies, Inc., CAT#:
RC212924) and empty vector (control) were used to generate the
overexpressing cell lines. Raw264.7 cells were transfected using
FuGENE 6 (Roche Diagnostics, Indianapolis, IN, USA) according to the
manufacturer's instructions. After 48 h of transfection, cells were
treated with G418 (800 μg/ml) until 14 days, and finally, SOD2 ex-
pressing clones were selected from the single colony by immunoblot
analysis probed against c-terminally tagged Flag protein with SOD2.
From now on, we will call this cell line as R.SOD2 cells.
2.3. SDS-PAGE and western blotting
Whole-cell lysates were prepared by washing the cells with ice-cold
PBS followed by lysis with lysis buffer (contain 60 mM Tris-HCl pH 7.5,
150 mM NaCl, 10 mM MgCl2, 2 mM EDTA, 10% glycerol, 1% Triton X-
100, 10 mM NaF, 2 mM PMSF, protease inhibitors (1 μg/ml each
aprotinin, antipain, pepstatin, leupeptin, 1 mM sodium orthovanadate
and 0.1 mM molybdic acid). For immunoblot analysis, proteins were
resolved on 7–10% polyacrylamide gels and transferred to the ni-
trocellulose membrane. The blots were probed with specific antibodies
(Supplemental Table S1) and developed with infrared-tagged secondary
antibodies and imaged through an Odyssey image scanner and analyzed
by Odyssey Infrared Imaging System application software (LiCor Inc.,
Lincoln, NE).
2.4. Redox blotting of Prx1 and Prx3
The posttranslational redox changes in the key cytosolic and mi-
tochondrial thiol proteins, such as peroxiredoxins (Prx1 and Prx3) were
probed by the redox immunoblot as described before [36–38]. Briefly,
treated and untreated cells were washed with Hanks’ balanced salt
solution and covered with NEM Buffer (0.1 M N-ethylmaleimide,
50 mM NaCl, 40 mM HEPES, pH 7.4, 1 mM phenylmethylsulfonyl
fluoride, 1 mM EDTA, 1 mM EGTA, and 10 μg/ml catalase and protease
inhibitors) for 2 min. Cells were collected and incubated in NEM buffer
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for 15 min at room temperature. Cells were pelleted down (5 min, 800
g) and lysed with NEM extract buffer supplemented with CHAPS in a
final concentration of 1%. Samples were kept at −80 °C until analysis.
NEM reacts with the –SH groups of the reduced forms of PRX to prevent
the oxidation during the cell harvesting and lysis. Reduced Prx1 and
Prx3 migrate as monomers (22 kDa) in SDS-PAGE, whereas the oxidized
proteins migrate as dimers (44 kDa). Lysates were thawed on ice and
then centrifuged for 5 min at 8000 g. 20 μg of protein extracts, com-
bined with nonreducing protein loading buffer (62.5 mM Tris–HCl pH
6.8, 10% glycerol, 2% SDS, 0.025% bromophenol blue) were resolved
by SDS-PAGE. The blots were probed with anti-Prx1 or anti-Prx3 anti-
bodies (Proteintech Group, Inc., Rosemont, IL), followed by the ap-
propriate IR-conjugated secondary antibody. Images were developed
through an Odyssey image scanner and quantified by Odyssey Infrared
Imaging System application software (LiCor Inc., Lincoln, NE).
2.5. Chromatin immunoprecipitation (ChIP) assay
ChIP assays were carried out with cells fixed with 1% formaldehyde
using a standard protocol. Immunoprecipitation with anti-HIF1α anti-
body (Santa Cruz Biotechnology) overnight at 4 °C. For each reaction,
1% of the sample was taken and pre-immune IgG was used as a negative
control. Antibody and Chromatin complex were immunoprecipitated by
protein A/G agarose beads with salmon sperm DNA (50% Slurry).
Eluted DNA-Protein complexes were reversed with 5 M NaCl at 65 °C
overnight. Immunoprecipitated DNA was purified and amplified by
PCR of HRE binding regions of human or mouse (as described in fig-
ures) EPO and VEGF promoters [39–41]. Data were presented as fold
enrichment by subtracting the signal with no antibody and expressed as
fold increase over the control sample.
2.6. Measurement of ROS production and fluorescent microscopy
ROS generation in whole cells was measured by the Amplex Red
hydrogen peroxide/peroxidase assay kit from Thermo Fisher (cat#
A22188). In brief, 8.5 × 104 cells were plated per well in the black
bottom 96 well plates with phenol-free complete DMEM medium. After
different treatments, the media was carefully removed and washed
gently with Krebs-Ringer phosphate buffer (KRPG, pH 7.35). KRPG
buffer consists of 145 mM NaCl, 5.7 mM sodium phosphate, 4.86 mM
KCl, 0.54 mM CaCl2, 1.22 mM MgCl2, 5.5 mM glucose and pH adjusted
to 7.35. Then cells were incubated with 50 μl 1 × reaction buffer
containing 50 μM Amplex Red, 10 U/ml horseradish peroxidase (HRP)
in KRPG buffer for 20 min at room temperature. The method involves
horseradish peroxidase (HRP)-catalyzed oxidation of the colorless and
nonfluorescent Amplex Red molecule to red-fluorescent resorufin, as
described earlier [42]. The fluorescence of resorufin was recorded with
an excitation set at 530 nm and emission set at 590 nm in a MicroWin
chameleon multilabel plate reader. ROS were also detected using hy-
droethidine (HE) probe coupled with HPLC-based detection of 2-OH-
E+, the superoxide-specific product, and other oxidation products, as
described elsewhere [43]. HPLC experiments were performed using an
Agilent 1100 system equipped with UV–visible absorption and fluor-
escence detectors for measuring the reaction products. Cellular oxidants
were also measured using MitoSOX Red (Thermo Fisher Scientific,
Catalogue #M36008) and following the manufacture's protocol. In
brief, treated cells were incubated with 5 μM MitoSOX reagent in Ca/
Mg-free HBSS buffer for 10 min in the dark, followed by washing three
times with PBS and finally fluorescence was recorded using a micro-
plate reader (Promega Glow Max Discover Plate reader) with excita-
tion/emission maxima of 510/580 nm.
Mitochondrial ROS also detected by using Olympus fluorescent
microscope (BX61, Camera Retiga 4000R). Cells were plated and grown
on cover slip (5 × 104 cells/well) in 12 well plates and incubated with
MitoPQ control and MitoPQ for 16 h at 37 °C. Following incubation,
cells were washed with 1 × PBS two times and incubated with 5 μM
MitoSOX and 200 nM Mitotracker Green (Thermo Fisher scientific,
Catalogue #M7514) in HBSS solution for 10 min in the dark at 37 °C.
Next, cells were washed thrice with 1 × PBS and subjected for fluor-
escent micrograph using TRITC (for MitoSOX) and FITC filter (For
Mitotracker Green) using Advanced Metamorph software.
2.7. Aconitase assay
Cell lysates were prepared in 50 mM Tris-Cl (pH 7.4), 1 mM L-cy-
steine, 0.6 mM MnCl2, 1 mM Na-citrate, and 0.5% Triton X-100 buffer
with protease inhibitors (2 mM PMSF, 1 μg/ml each aprotinin, antipain,
pepstatin, leupeptin). Aconitase activity was measured with 200 μg of
protein in 50 mM Tris-Cl (pH 7.4), 30 mM Na-citrate, 0.6 mM MnCl2,
0.2 mM NADP, 0.2% Triton X-100 with 4 U/ml isocitrate dehy-
drogenase, by following the formation of NADPH, measured at 340 nm
wavelength, for 15–25 min. The time range of linear increase in the
absorbance over time was used for the determination of aconitase ac-
tivity [44,45]. To measure the aconitase activity in hypoxia-treated or
following treatment with mitochondrial agents, cells from each treat-
ment group were divided into two portions: One portion was used for
immunoblot analysis, and the other was used for colorimetric mea-
surement of aconitase activity.
2.8. Calcineurin assay
Cn activity was measured using the Cn cellular activity assay kit
(Enzo Life sciences, Farmingdale, NY, USA) according to the manu-
facturer's suggested protocol. In brief, the cultured cells were washed
and collected by centrifugation in Tris buffer saline (pH 7.4). Cell ex-
tracts were prepared by disrupting the cells by lysis buffer (provided)
with protease and phosphatase inhibitors (provided). According to the
manufacturer's instruction, the phosphopeptide substrate was in-
cubated with cell extract except to phosphate standard curve samples
for 10 min at 30 °C in 96 well clear bottom plate. Assays were initiated
by adding the calcineurin (40 U/well) or the cell extract (5 μg) and
incubated for 30 min at 30 °C. The kit measures free phosphate released
from the Cn-specific RII phosphopeptide. Free phosphate released was
measured using malachite green at 620 nm. Cn-specific phosphatase
activity was calculated by subtracting activity in the presence of EGTA
from total phosphatase activity.
2.9. Matrigel invasion assay
Matrigel invasion assays were performed in triplicate for each group
using 24 well plate transwell chambers (8 μm pore, Corning, NY).
Initially, 100 μl (200 μg/ml) Corning matrigel matrix was used to coat
the top part of the membrane. 2.5 × 104 cells/well were seeded for
each group with required treatments, as mentioned in Fig. 700 μl
DMEM containing 20% FBS was kept in basolateral chambers and in-
cubated for 14–16 h at 37 °C in a 5% CO2 incubator. Cells were then
fixed with chilled methanol and incubated for 6 min in hematoxylin
solution Gill 3 (Sigma-Aldrich, St. Louis, MO) for cell staining. Non-
invading cells were removed from the top of the Matrigel coat layer
using a wet cotton swab. Images were taken using an Olympus BX-61
upright microscope (Olympus-Life sciences) with 10 × objective lens.
Five random visual fields were selected for counting and represented as
the number of invading cells per field.
2.10. Measurement of mitochondrial membrane potential
The mitochondrial membrane potential (ΔΨm) was measured using
tetramethylrhodamine ethyl ester (TMRE) (Sigma-Aldrich, St. Louis,
MO). In brief, 1 × 106 live cells were washed with PBS at room tem-
perature, re-suspended in 1 ml phenol-free medium without FBS, sup-
plemented with 50 nM TMRE and incubated in the dark for 10 min at
37 °C. As a positive control, 10 μM carbonyl cyanide p-
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trifluoromethoxyphenylhydrazone (FCCP) was used to disrupt ΔΨm.
Fluorescence intensity of TMRE was measured by Cellometer Vision
CBA (Nexcelom Biosciences, Lawrence, MA) by setting the filter ex-
citation at 502 nm and emission at 595 nm.
2.11. AMPK assay
The level of activated AMPK in cells was assayed using an ELISA kit
(Abcam, ab181422) to measure AMPK-α phosphorylation at Thr172,
following the manufacturer's instructions and standards provided in the
kit.
2.12. Realtime PCR for mRNA quantification
Total RNA was isolated using TRIzol reagent as per the vendor's
protocol (Invitrogen). cDNA was generated from 1 μg of RNA using the
cDNA Archives kit from Applied Biosystems (Thermo Fisher Scientific,
Waltham, MA), and 25 ng of this cDNA was used as template per re-
action. mRNA levels were quantified using SYBR Green (Applied
Biosystems) in a Quant Studio 6 Flex real-time PCR system (Applied
Biosystems). Data were normalized to β-actin as endogenous control,
and relative expression of target genes was expressed using the 2−ΔΔCt
method and the used primers listed in supplemental Table S2.
2.13. Cell viability
Raw264.7 cells (8.5 × 104 cells/well) were incubated in 96-well
plates. Following different treatments and 16 h of incubation, 20 μL of
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS;
Promega, Madison, WI, USA) reagent was added to each well and then
incubated for 2 h at 37 °C. The assay is based on phenazine ethosulfate-
mediated reduction of MTS tetrazolium salt to a water-soluble for-
mazan. The absorbance at 490 nm due to the formation of formazan
was measured using a microplate reader (Promega Glow Max Discover
Plate reader).
2.14. Statistical analysis
Statistical analyses were carried out using Microsoft Excel or
GraphPad Prism Software. Statistical significance was determined by an
unpaired two-tailed Student's t-test and paired when needed and
equality of variance was checked using one-way ANOVA test. All the
data for the in vitro experiments have been presented as means ± S.D.
of at least three data points from three different experiments. p-values
≤ 0.05 were considered statistically significant and p-values ≤ 0.01
were considered highly significant.
3. Results
3.1. Timeline for induction of nuclear HIF1α and cytoplasmic Cn under
hypoxia in Raw264.7 cell line
To evaluate the role of mitochondrial ROS in different signaling
pathways, we first exposed Raw264.7 cells to hypoxic conditions (1%
O2) for different time periods. This treatment resulted in HIF1α protein
accumulation starting from about 4 to 6 h and continuing until 12 h of
hypoxia (Fig. 1A). In contrast, Cn was activated by over 10-fold as early
as 2 h after initiation of hypoxia, and remained at that level for at least
12 h (Fig. 1B). We took a genetic approach to generate stable mi-
tochondrial superoxide dismutase-2 (SOD2) expressing Raw264.7 cell
line (as described in Methods, Fig. S2B), which we named R.SOD2 cells.
This stable cell line was generated, to see if the scavenging of mi-
tochondrial superoxide can take away the free radical's effect on MtRS.
A high increase in Cn activity due to hypoxia was diminished with
mitochondrial SOD2 expression (Fig. 1B) proves the involvement of
mitochondrial O2•– in MtRS. Mitochondrial aconitase activity is highly
sensitive to mitochondrial O2•– and its inactivation has been used as a
vital oxidative stress marker [45,46]. Results presented in Fig. 1C show
that aconitase activity was inhibited by about 45% after 2 h of hypoxia,
and continued to decline steadily until 12 h of hypoxia, suggesting a
cumulative effect. The mitochondrial membrane potential, ΔΨm, which
is a direct reflection of mitochondrial function, as measured by mon-
itoring the accumulation of TMRE, revealed that ΔΨm was reduced by
about 20% by 2 h of hypoxia, and continued to decrease steadily until
12 h of hypoxia. The mitochondrial protonophore FCCP (10 μM), used
as a control, caused the maximal disruption of ΔΨm (Fig. 1D). Finally,
real-time qPCR data of gene targets of the HIF1α transcription factor
shows that erythropoietin and VEGF transcripts are increased gradually
up to 6 h of hypoxia and were further pronounced increase at 12 h of
hypoxia (Fig. 1E). Moreover, ChIP analysis of the VEGFα promoter
demonstrates high levels of HIF1α factor binding by 6 h and continued
to increase over the 12 h period of hypoxia (Fig. 1F). Notably, the in-
duction of HIF1α marker genes is markedly slower than the Ca2+/cal-
modulin dependent activation of Cn (Fig. 1G) and Ca2+/Cn retrograde
signaling markers, RyR, IGF1R, and Glut 4 mRNAs were induced by
about 2–4 h of hypoxia and reached the maximum level by 6–8 h of
hypoxia (Fig. 1H). In contrast, cathepsin L mRNA was induced maxi-
mally at 2 h of hypoxia and trended to decline by 6–12 h of hypoxia.
Thus, under hypoxic conditions, both pathways are activated, but the
kinetics of induction of HIF1α marker genes are markedly slower than
the time frame for the initiation of Ca2+/Cn pathway gene expression.
3.2. Effects of mitochondrially targeted agents on Raw264.7 macrophages
We next explored the impact of mitochondria-targeted agents
MitoPQ and MitoMet that were reported previously to induce mi-
tochondrial superoxide generation and affect mitochondrial function in
different cells. Similar to other TPP+ conjugated compounds reported
in the literature [33–35,47], the two mitochondrially targeted agents
used in this study accumulate in the mitochondrial matrix to a sig-
nificantly higher extent than in the cytoplasm and other subcellular
compartments [33]. Fig. S1 shows the structures of all four compounds
used, i.e., decyl-TPP+ (DTPP+), which is a common control for both
mitochondria-targeted PQ and Metformin, MitoPQ-control in which a
non-redox cycling bipyridinium moiety attached to DTPP+, MitoPQ,
and MitoMet. Previous studies showed that DTPP+ inhibited mi-
tochondrial respiration at high doses [35,48]. We, therefore, used both
DTPP+ and MitoPQ-control for the analysis of ROS production and
mitochondrial stress signaling as negative controls.
MitoPQ produces mitochondrial ROS by redox recycling at complex
I, while MitoMet produces ROS by inhibiting complex I [21,33,49,50].
As shown in Fig. 2A, Raw 264.7 macrophages were treated with dif-
ferent doses of control compounds, and the two test compounds se-
lected based on the dose-dependent inhibition of aconitase (Fig. S2A).
Increased production of O2•– leads to higher levels of H2O2 which can be
conveniently measured in the extracellular medium using Amplex Red
assay (Fig. 2A) by fluorometry. We also used HPLC-based profiling of
hydroethidine oxidation products, including the measurement of 2-
hydroxyethidium (2-OH-E+), a product of the reaction of hydroethidine
with superoxide (Fig. 2B). Additionally, fluorometrically, we measured
MitoSOX-derived red fluorescence (Fig. S3A) generated by cellular
oxidants in response to treatment. In addition, a fluorescent micrograph
of MitoSOX loaded cells with Mitotracker green is presented in Fig. S3B.
We found that both MitoMet and MitoPQ induced higher levels of
oxidants when used at 0.5 and 1 μM concentrations than did the two
control compounds used (Fig. S3A). While 0.5 μMMitoPQ-control alone
produced marginal fluorescence above the untreated control, 0.5 μM
MitoMet or MitoPQ produced nearly 3-fold higher fluorescence in-
tensity and 1 μM MitoMet produced an even higher level. In the hy-
droethidine assay (Fig. 2B), the compounds increased the cellular level
of the superoxide-specific 2-OH-E+ product, when compared to treat-
ment with MitoPQ-control.
A.R. Chowdhury, et al. Redox Biology 36 (2020) 101606
4
MitoMet and MitoPQ, when used at the concentration of 1 μM
(p ≤ 0.01) and 2 μM (p ≤ 0.01) decreased cell viability to a higher
extent (20–30%) than did the two control compounds or metformin
alone (Fig. S3C). We also measured mitochondrial membrane potential,
ΔΨm, after treatment with the four compounds using the TMRE probe
(Fig. 2C). While treatment with MitoPQ control and DTPP+ up to
0.5 μM did not affect ΔΨm, 0.5 μM MitoPQ disrupted the transmem-
brane potential significantly (Fig. 2C). Additionally, the disruptive ef-
fect of MitoPQ was attenuated by the addition of 10 mM NAC (N-
acetylcysteine), a known antioxidant. MitoMet at both 0.5 μM and 1 μM
levels markedly disrupted ΔΨm (Fig. 2C).
We then investigated the levels of HIF1α by immunoblot analysis,
inactivation of cellular aconitase (Fig. S2A), and the Cn assay to assess
Ca2+/Cn activation, as described in the Methods section. Cn activity
(Fig. 2D) induced by treatment with 0.25 μM and 0.5 μM MitoPQ in a
dose-dependent fashion. MitoMet treatments (0.5 μM and 1 μM) also
increased the Ca2+/Cn activation in Raw cells. While 0.5 μMmetformin
by itself did not induce Cn activity, Cn activity marginally induced at
1 μM (Fig. 2D) metformin treatment. Thus, mitochondria-targeted
compounds were significantly more effective. We then evaluated the
impact of mitochondrial oxidants on the accumulation of HIF1α and Cn
proteins following treatment with either MitoPQ-control or MitoPQ
(Fig. 2E and F). Immunoblot analysis shows that the HIF1α levels re-
mained nearly undetectable in the total extracts of Raw 264.7 macro-
phages treated with different concentrations of MitoPQ-control as well
as MitoPQ (Fig. 2E). Even 0.5 μM MitoPQ, which induced ROS pro-
duction, did not show detectable HIF1α induction (Fig. 2E), suggesting
that these agents do not stabilize HIF1α. In contrast, and in support of
the Cn activity presented in Fig. 2D, the Cn protein level was induced by
both 0.25 μM and 0.5 μM MitoPQ (Fig. 2F), but not by MitoPQ-control
up to 0.5 μM level tested (Fig. 2F). The Cn activity by mitochondria-
targeted agents were reversed to near normal level in SOD2 over-
expressing R.SOD2 cells (Fig. 2D).
Similar approaches were used to test the effects of MitoMet.
Immunoblot analysis shows that neither MitoMet nor metformin in-
duced any detectable HIF1α protein accumulation (Fig. 3A). In support
of immunoblot data indicating that HIF1α is not stabilized by MitoPQ,
ChIP analysis of Epo promoter DNA revealed that MitoPQ control,
MitoMet, as well as MitoPQ, were unable to induce occupancy of HIF1α
on the target promoters under in vitro conditions. In contrast, hypoxia-
grown cells showed a high level of promoter occupancy by HIF1α
(Fig. 3B). Similar to MitoPQ, both MitoMet and unconjugated
Fig. 1. Downstream effects of HIF1α
and calcineurin A in response to hy-
poxia. Raw264.7 cells were grown
under hypoxia for different time points
(0–12h) and each group was divided
into two subgroups for immunoblot and
biochemical assays. A, a representative
immunoblot analysis for HIF1α and
GAPDH as loading control, using 40 μg
of cell extract in each case. B, calci-
neurin activity was assayed by using an
assay kit as described in the Materials &
Methods. C, Aconitase activity assay
was performed with 200 μg of total cell
lysates as an indicator of oxidative
stress and expressed as nmol/min/mg
of protein. D, mitochondrial membrane
potential (ΔΨm) was measured using
TMRE and presented as mean fluores-
cence intensity (A.U.). E, Hypoxia in-
duced changes in erythropoietin (Epo)
and VEGFα mRNA levels. The mRNA
levels were monitored by qRT-PCR
analysis. Results from 3 independent
experiments (n = 3) were normalized
to β-actin mRNA levels and expressed as
a fold change over the normoxic con-
trol. F, Chromatin immunoprecipitation
(ChIP) analysis was performed on a
HIF1α binding site located on VEGFα
promoter at nucleoside −944 to −831
from the transcription start site and
enrichment of HIF1α on VEGFα pro-
moter was measured in Raw cells after
hypoxic stimulation (n = 3 for all
groups). Data represent mean ± S.D.
G, the graph represents the fold in-
crease of Cn activity (means ± S.D.,
n = 3) relative to VEGFα and Epo
mRNA levels at each time point of hy-
poxia after normalization to control. H,
mRNA expression profile of different
MtRS signaling markers at different
time of hypoxia. The mRNA levels were
measured by qRT-PCR analysis. Results
from 3 independent experiments (n = 3) were normalized to beta actin mRNA levels and expressed as a fold change over the normoxic control. Values showing
significant differences from control or individual groups are indicated with an asterisk (*p < 0.05, **p < 0.01).
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metformin showed increased Cn protein levels (Fig. 3C). Although not
shown, Cn activity was induced under these treatment conditions. In
agreement with the Cn induction results (Fig. 3C), the aconitase activity
assay shows that MitoMet at 0.5 μM and 1 μM level, as well as un-
conjugated metformin at 1 μM and 2 μM levels, inhibited aconitase,
suggesting induction of oxidative stress (Fig. 3D). In order to validate
the generation of mitochondrial oxidant, we used non-reducing SDS-
PAGE gel and immunoblotting to check the conversion of reduced
peroxiredoxin (22 kDa) to oxidized form (44 kDa). Mitochondrial per-
oxiredoxin 3 (Prx3) and cytosolic peroxiredoxin 1 (Prx1) are the en-
dogenous indicators of compartmental redox state [51]. Prx3, which
scavenges mitochondrial H2O2 [34], changes from reduced monomer to
oxidized dimer upon cell treatment with MitoPQ (Fig. S4A) and Mi-
toMet (Fig. S4B) with only moderate effects on the redox state of cy-
tosolic Prx1. More pronounced oxidation effect of Prx3 was observed in
MitoPQ treatment when compared with control MitoPQ. 70–80% of
Prx3 was oxidized upon the treatment with 0.25 μM and 0.5 μMMitoPQ
(Fig. S4C), while about 60% of oxidized Prx3 protein was observed
upon treatment with MitoMet (0.5 μM and 1.0 μM), as shown in Fig.
S4D. These results indicate that mitochondria are the primary source of
ROS upon cell treatment with MitoPQ and MitoMet. However, we did
not see any significant changes in the total (oxidized + reduced)
amount of Prx1 and Prx3 (Fig. S4 E and F). These results collectively
show that both MitoMet and MitoPQ induce oxidant production, inhibit
aconitase activity, and induce Cn activity but do not contribute sig-
nificantly to HIF1α activation.
Low O2 levels inhibit the post-translational modification of HIF1α
by blocking PHD-mediated ubiquitination and degradation [52]. Dif-
ferent concentrations of MitoPQ treatment in Raw264.7 cells did not
change the levels of PHD1 or PHD3 compared to the control untreated
cells and cells treated with MitoPQ control (Fig. 3E). On the other hand,
PHD2 levels gradually decreased following treatment with relatively
high doses (1.5 μM and 2.5 μM) of MitoPQ. These results support our
finding that mitochondria-targeted ROS inducers did not stabilize
HIF1α for up to 16 h of treatment tested.
3.3. MitoPQ and MitoMet induce calcineurin activity in other cell types as
well
To determine the potential role of the Cn signaling pathway in
MtRS, we evaluated the effects of hypoxia (2–8 h) as well as the mi-
tochondria-targeted agents, MitoPQ and MitoMet (16 h) on HCT116
and C2C12 cells. Immunoblot analysis of HCT116 WT and HCT116
p53−/− cells grown under hypoxia for different lengths of time re-
vealed that HIF1α protein starts accumulating at 4 h of hypoxia
(Fig. 4A). As previously shown for Raw264.7 macrophages, Cn activity
is induced to about 2.2-fold after 2 h of hypoxia and remains at this
level until 12 h in HCT116 cells (Fig. 4B). While MitoPQ control at
either 0.25 μM or 0.5 μM did not induce Cn activity beyond the un-
treated control cell level, the same concentrations of MitoPQ induced
near 3-fold activity (Fig. 4C). On the other hand, there was no sig-
nificant HIF1α activation by either MitoPQ control or MitoPQ as shown
Fig. 2. Effects of mitochondria targeted pro-oxi-
dant MitoPQ on subcellular redox state. ROS
generation was assayed in Raw264.7 cells that were
either untreated or treated with MitoPQ control,
MitoPQ or MitoMet and DTPP + for 16 h at the
indicated concentrations. A, ROS generation was
measured by Amplex Red assay (n = 3 independent
experiments, in duplicate). Fluorescence values
were normalized to cell number. B, Effects on su-
peroxide production. Superoxide was measured
using hydroethidine, as described in Materials and
Methods. Results are mean ± S.D. (n = 3). C, mi-
tochondrial membrane potential was measured
using TMRE and represented as mean fluorescent
intensity (A.U.) D, calcineurin activity was assayed
by calcineurin cellular activity assay kit as nmol of
phosphate released. E & F, a representative im-
munoblot analysis of proteins for HIF1α, calcineurin
A and loading control GAPDH following MitoPQ
control or MitoPQ treatment (n = 3). Significance
was calculated by one-way ANOVA with Tukey's
multiple-comparison test, and data are presented as
treatment group versus no-treatment control. In all
experiments error bars represent standard devia-
tions (*p < 0.05, **p < 0.01). (For interpretation
of the references to color in this figure legend, the
reader is referred to the Web version of this article.)
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by the occupancy of Epo promoter DNA sites by HIF1α protein (Fig. 4F,
left hand panel). Growth of HCT116 cells under hypoxia for 6 h,
however, yields high enrichment of HIF1α by ChIP analysis.
Immunoblot analysis also revealed the time dependent accumula-
tion of HIF1α protein in C2C12 myoblasts exposed to hypoxia 4 and 8 h
(Fig. 4D). Although not shown, Cn activation in these cells occurs at 2 h
of hypoxia. While treatment of C2C12 cells for 16 h with 0.25 μM and
0.5 μM MitoPQ control failed to induce Cn activation above the basal
untreated cell level (Fig. 4E), treatment with 0.25 μM and 0.5 μM Mi-
toPQ and 1 μM MitoMet induced Cn activation by 2.5 to 3-fold. The
addition of 1 μM unconjugated metformin alone did not induce sig-
nificant Cn activity. Furthermore, the ChIP analysis of both 0.5 μM
MitoPQ-control and MitoPQ failed to show any enrichment of HIF1α
binding to the Epo promoter DNA, whereas 4 h hypoxia treated
C2C12 cells showed high enrichment of HIF1α binding (Fig. 4F, right
hand panel). Together, these results show that while hypoxia induces
both Cn and HIF1α activation in time separated fashion, mitochondria-
targeted agents failed to show any HIF1α activation under the same
experimental conditions that activate Cn.
3.4. Mitochondrial ROS and AMPK activity in Raw264.7 and C2C12 cells
AMPK signaling is an essential pathway for balancing glycolysis and
mitochondrial oxidative metabolism and is activated when mitochon-
drial ATP production goes down [53]. Moreover, in cancer cells under
metabolic stress, AMPK can induce ATP generation from non-glucose
substrates. H2O2 generation by glucose oxidase promotes AMPK acti-
vation. Here, we determined if AMPK activity was induced by mi-
tochondrial oxidants stimulated by MitoPQ, MitoMet and MitoPQ-
control. We did not observe any increase in AMPK activity at con-
centrations of MitoPQ and MitoMet that induced Cn signaling (Fig. 5A).
Immunoblot analysis shows no significant increase in AMPKα levels
with similar treatment of either C2C12 or Raw264.7 cells (Fig. 5B) and
a modest increase in AMPK phosphorylation by drug treatment
(Fig. 5B).
3.4.1. Induction of mitochondrial retrograde signaling markers in response
to mitochondria-targeted agents
We next analyzed the marker genes for Cn mediated MtRS, in-
cluding Cathepsin L and TGF-βmRNAs. Realtime qPCR results show that
in HCT116 cells, Cn targets were induced by 2 h of hypoxia and levels
were maintained up to 12 h of hypoxia (Fig. 5C). Cathepsin LmRNA was
Fig. 3. Effects of mitochondria-targeted MitoPQ
and MitoMet on subcellular redox state.
Raw264.7 cells were treated with either DTPP + or
TPP + conjugated metformin, MitoPQ or un-
conjugated metformin for 16 h at the indicated
doses. A, a representative immunoblot analysis of
HIF1α and loading control GAPDH (n = 3). B, ChIP
analysis was performed for HIF1α binding site on
Epo promoter site and enrichment of HIF1α binding
was determined (n = 3 for all groups). Data are
shown as mean ± S.D. C, a representative im-
munoblot analysis of Calcineurin A and loading
control GAPDH. D Aconitase activity assay was
performed with 200 μg of total cell lysates as an
indicator of oxidative stress and expressed as nmol/
min/mg of protein. (means ± S.D., n = 3). E, a
representative immunoblot analysis of cell extracts
for PHD1, PHD2, PHD3 and loading control GAPDH
following treatment with indicated doses of MitoPQ
and MitoPQ control. Significance was calculated by
one-way ANOVA with Tukey's multiple-comparison
test, and data are presented as treatment group
versus no-treatment control. In all experiments error
bars represent standard deviations (*p < 0.05,
**p < 0.01).
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induced by 2 h of hypoxia and came down steadily with longer hours of
hypoxia (Fig. 5D). The reason for this decline is unclear. TGF-β mRNA
was induced marginally by 2 h of hypoxia but more robustly (2.5 to 3-
fold) by 4 h and beyond (Fig. 5E).
It was shown that in C2C12 and other cell types, activation of Cn-
mediated MtRS induced invasive behavior, as assessed by invasion
through a Matrigel membrane layer [54–56]. When tested with 0.5 μM
MitoMet and MitoPQ, HCT116 cells showed high level of invasiveness,
while treatment with 0.5 μM MitoPQ-control alone had no significant
effect (Fig. 5F and G). These results confirm that mitochondria-targeted
oxidants induce MtRS as seen by the induction of biomarkers, including
invasive behavior.
3.5. Complex III mediated ROS and HIF1α accumulations
Antimycin A (AA) is a known inhibitor of cytochrome bc1 complex
and promotes ROS production 4 times faster than basal levels in bovine
heart mitochondria [57] in vitro. We, therefore, tested the effects of AA
Fig. 4. Effects of mitochondria-targeted agents
on the activation of signaling pathways in
HCT116 and C2C12 cells. HCT116, HCT116p53−/
− and C2C12 cells were exposed to hypoxia for
different time points or treated with different mi-
tochondria-targeted agents for indicated time and
concentrations. A, immunoblot analysis of HIF1α
and loading control GAPDH for the indicated cell
lines. B–C, calcineurin activity was assayed by cal-
cineurin cellular activity assay kit and nmol of
phosphate released/mg of protein was plotted
(means ± S.D., n = 3). D, immunoblot analysis of
C2C12 cells subjected to hypoxia for HIF1α and
loading control GAPDH. The blots are representative
of three different runs. E, calcineurin activity, with
or without treatment with mitochondria-targeted
prooxidants in C2C12 cells. Activity was measured
by calcineurin activity assay kit and (means ± S.D,
n = 3). F, ChIP analysis was performed on a HIF1α
binding site of Epo promoter to evaluate promoter
occupancy by HIF1α in HCT116 and C2C12 cells
after treatment with TPP+, MitoPQ for 16hr or
hypoxia exposure for 12 h (n = 3 for all groups).
Data represent mean ± S.D. The significance was
calculated by one-way ANOVA with Tukey's mul-
tiple-comparison test, and data are presented as
treatment group versus no-treatment control. In all
experiments error bars represent standard devia-
tions (*p < 0.05, **p < 0.01).
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on Raw264.7 cells (Fig. 6A). At 0.625 μM and 1.25 μM level, AA sig-
nificantly induced H2O2 production, as measured by using the Amplex
Red assay (Fig. 6A). Treatment with AA caused pronounced oxidation
of mitochondrial Prx3 in comparison to cytosolic Prx1, indicating mi-
tochondrial generation of ROS (Fig. S5) in treated Raw264.7 cells.
However, AA up to the maximum range of 5.0 μM failed to induce any
accumulation of HIF1α protein in Raw264.7 cells (Fig. 6B). As the
phosphorylation status of p38 changes in response to ROS generation,
we next evaluated the p38 phosphorylation status in AA treated cells.
As expected, phosphorylation of p38 gradually increased with in-
creasing concentrations of AA for 2 h (Fig. 6B). At higher concentra-
tions of AA (2.0 μM), phosphorylation of p38 was significantly higher
(Fig. 6B). Induction of AMPK phosphorylation was observed at 1.0 μM
and 2.0 μM of AA treated cells. In contrast, as shown in Fig. 5B, TPP+-
linked mitochondria targeted agents that can initiate ROS production
did not have any significant effect on AMPK phosphorylation. In ad-
dition, the level of the catalytic subunit of Cn induced by low doses of
AA and further decreased with increasing AA doses (Fig. 6C). These
results suggest that ROS generated by complex III inhibitors did not
stabilize the HIF1α protein under the current experimental conditions
though it did activate Ca2+/Cn and AMPK pathways.
Immunoblot in Fig. S6 shows that both MitoPQ and MitoMet did not
induce the accumulation of oxidative stress-responsive transcription
factor NRF-2 in a significant manner. This is consistent with the results
in Figs. S3 and S4.
4. Discussion
MtRS, also called mitochondrial stress signaling, plays a role in
many pathophysiological processes including cancer [58], aging, neu-
rodegeneration [12], and even in innate immunity [59]. More recently,
mitochondrial stress has also been implicated in mitohormesis, a pro-
cess of preconditioning cells or tissues against oxidative stress-induced
injury or mitochondrial mutations [47,60]. There are several effector
pathways elicited by MtRS, including the AMPK pathway [61] that can
promote insulin resistance and reflects the metabolic state of cells [62],
Fig. 5. Effects of pro-oxidants on
AMPK activity and Cn pathay.
AMPKα (Thr172) activity in Raw264.7
and C2C12 cells were measured fol-
lowing treatment with DTPP + control
or TPP + conjugated agents (MitoPQ
and MitoMet) for 16 h at the indicated
doses. A, Phosphorylated AMPKα level
was measured in Raw264.7 cells and
C2C12 cells. B, immunoblot analysis of
phosphor-AMPKα protein along with
GAPDH as loading control. The Bar
diagram representing (the band in-
tensity AMPKα Phos/tolal) The blots
are representative of three different
runs (n = 3). C-E, mRNA expression
profile of different MtRS signaling
markers at different time of hypoxia in
HCT116 cells. The mRNA levels were
monitored in qRT-PCR assays. The re-
sults from 3 independent experiments
and normalized to beta actin mRNA
levels and expressed as a fold change
over the normoxic control. F, Matrigel
invasion of control HCT116 cells
treated with or without mito-targeted
agents for 16h, before cells were loaded
in to the chamber. G, quantitation of
invading cells from triplicate experi-
ments as in F. Significance was calcu-
lated by one-way ANOVA with Tukey's
multiple-comparison test, and data are
presented as treatment group versus no-
treatment control. In all experiments,
error bars represent standard deviations
(*p < 0.05, **p < 0.01).
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the HIF1α pathway, which is implicated in cancer initiation and pro-
gression and also in other diseases, mitochondrial UPR signaling that
has been implicated in resistance to pathogenic infection [2], and the
Ca2+/Cn signaling pathway which is involved in tumor development
and cardiac dysfunction. This study provides a comparative view of
three different signaling pathways initiated by mitochondrial dysfunc-
tion.
Recently, mitochondrial ROS have received special attention as a
causative factor in many pathological processes through activation of
MtRS [13,63]. Some studies suggest that ROS-induced signaling in-
variably involves both HIF1α and AMPK activation [19,31]. However,
in our laboratory, we have shown that the disrupted ΔΨm can also
induce the Ca2+/Cn signaling pathway [13] in multiple modes of mi-
tochondrial dysfunction, including reduced mtDNA content [23], cy-
tochrome c oxidase disruption [54], disruption of IKBβ, which supports
Cn-mediated NFκβ activation [64], and hypoxia [30]. This pathway
activates multiple transcription factors and causes a change in nuclear
gene expression program [9]. As it currently remains unclear how or if
the HIF1α, AMPK, and Ca2+/Cn activation pathways are related, we
undertook a comparative analysis of the three MtRS pathways under
hypoxic conditions and following stimulation of mitochondrial oxi-
dants. We did not evaluate the mtUPR pathway since the threshold of
oxidative stress needed for mtUPR activation and the transcription
factors involved are quite different from the Ca2+/Cn [9], HIF1α [19]
and AMPK pathways [31]. Nor did we evaluate pathways leading to
mitohormesis, which can be induced by very low levels (< 0.1 μM) of
MitoPQ to provide protection against ischemia-induced myocardial
dysfunction [47].
Using hypoxia and mitochondria-targeted agents (MitoPQ and
MitoMet) as inducers of mitochondrial ROS [33,34], we have carefully
evaluated the dose and time-dependent activation of the three path-
ways, i.e., Ca2+/Cn, HIF1α and AMPK and their target gene expression
to understand the time-frame of their activation and the relationship, if
any, between these pathways. Several tangible mechanisms have been
proposed for the role of mitochondrial ROS in HIF1α activation and
AMPK activation [19,65] though there exist differences of opinions on
each of the pathways. In the case of ROS mediated Ca2+/Cn activation,
which also can get activated by proline dependent ROS [66], we believe
that the direct attack of ROS on mitochondrial inner membrane com-
ponents leads to disruption of ΔΨm and an associated increase in cy-
toplasmic Ca2+. In support of this possibility, we have shown that
myocardial ischemia/reperfusion and/or hypoxia induce selective de-
gradation of CcO subunits I, IVi1 and Vb, causing disruption of ΔΨm
[61]. Similarly, Lesnefski's group has shown that hypoxia and mi-
tochondrial ROS induce peroxidation of cardiolipin that is important for
CcO function [65]. Other mitochondrial reactive species such as NO and
CO can also affect CcO function by direct binding to the heme com-
ponents of CcO [67], suggesting the involvement of other species in
disturbing membrane integrity and induction of stress signaling [68].
Our results with hypoxia (Figs. 1 and 4) clearly show that activation of
Cn occurs by 2–4 h of hypoxia, while the activation of HIF1α, as tested
by the most sensitive ChIP analysis, is a significantly delayed process.
The same is true with AMPK level (Fig. 5A). Thus, we believe that the
Ca2+/Cn pathway, with its distinct molecular targets, is the most sen-
sitive to oxidant-mediated upregulation. Furthermore, some studies
suggest that calcium/calmodulin dependent protein kinase II activity is
also induced under cellular ROS environment [69,70]. Finally, it is
clear from our current and published data [32] that Ca2+/Cn pathway
functions independently of the other two pathways and, in most studies
involving mitochondrial ROS, one is expected to see the compounding
effects on all three pathways.
The use of mitochondria-targeted agents MitoMet and MitoPQ
[33,34] in three different cell lines clearly supports the above conclu-
sion. First, both agents at sub-toxic levels induce Ca2+/Cn but failed to
induce detectable HIF1α or AMPK activation (Figs. 2, 3 and 5A). As
shown in Figs. 1H and 5, these agents also induce the activation of
Ca2+/Cn-dependent stress target genes (RyR, Glut4, IGF1R, TGFβ, etc.)
and in vitro Matrigel invasion by C2C12 cells, which is a gold standard
biomarker of retrograde signaling through Ca2+/Cn activation. These
results suggest that the HIF1α activation and AMPK activation require a
higher threshold of mitochondrial ROS production than that is achieved
by these mitochondria-targeted agents. The results with these drugs are
of particular significance because of their ability to act more selectively
on mitochondrial targets. In addition, since they form a steep gradient
with the highest concentration in the mitochondrial matrix compart-
ment, they cause significantly less damage in other subcellular
Fig. 6. Effects of Complex III inhibitor on HIF1α.
ROS generation in Raw264.7 cells in response to
treatment with antimycin A for 2h at the indicated
concentrations. A, ROS generation was measured by
Amplex Red assay (n = 3 independent experiments,
in duplicate). Fluorescent values were normalized to
cell number. Significance was calculated by one-way
ANOVA with Tukey's multiple-comparison test, and
data are presented as treatment group versus no-
treatment control. In all experiments error bars re-
present standard deviations (*p < 0.05,
**p < 0.01). B, Representative immunoblots of
HIF1α, p38, phosphorylated p38, phosphorylated
AMPKα proteins and GAPDH as loading control. C.
Immunoblot analysis of Raw 264.7 cell extracts
treated with indicated concentrations of AA for 2h.
GAPDH was used as a loading control. The blots are
representative of three different runs. (For inter-
pretation of the references to color in this figure
legend, the reader is referred to the Web version of
this article.)
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compartments.
ETC complex III is another critical site for ROS production [65]. We
tested the effects of complex III inhibitor AA on HIF1α activation and
AMPK activation. Complex III inhibition by AA led to AMPK activation,
as seen by the increase in phosphorylated AMPKα and its dependent
p38 (Fig. 6). However, AA at high levels (up to 5 μM) did not induce
HIF1α protein accumulation or inhibit PDH level (Fig. 6) under the
present experimental conditions.
In summary, this study, compares the effects of different modes and
doses of mitochondrial ROS on the three mitochondrial stress induced
signaling pathways. Based on our results, we conclude that Ca2+/Cn
pathway is the most sensitive, as it is activated even at low thresholds of
mitochondrial ROS (see Fig. 7). In that regard, the Ca2+/Cn pathway is
likely to be important in communicating the dynamic aspects of mi-
tochondrial metabolic and energy status with the nuclear compartment.
However, under higher oxidative stress conditions such as hypoxia, all
three stress signaling pathways may be activated and function con-
cordantly to influence the cellular response to stress. The ability of very
low levels (0.1 μM) MitoPQ-induced ROS to provide cardioprotection
by inducing mitohormesis [47], while high levels (1–2 μM) of MitoMet
inhibiting cell proliferation [34], supports the dose-dependent nature of
these varied MtRS signaling cascades.
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